PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New disease-resistant food crops in prospect

2010-11-19
(Press-News.org) Researchers have uncovered the genetic basis of remarkable broad-spectrum resistance to a viral infection that, in some parts of the world, is the most important pathogen affecting leafy and arable brassica crops including broccoli, cauliflower, cabbage, kale, swede and oilseed rape. They have tested resistant plants against a range of different strains of the virus taken from all over the world and so far, no strain has been able to overcome the resistance.

The research on the so-called Turnip mosaic virus (TuMV), led by Dr John Walsh of the University of Warwick and funded under the BBSRC Crop Science Initiative, has been taken forward in a new partnership with Syngenta Seeds.

Dr Walsh said "TuMV causes really nasty-looking black necrotic spots on the plants it infects - 'a pox on your' vegetables! This can cause significant yield losses and often leaves an entire crop unfit for marketing. At best, a field of badly affected Brussels sprouts might provide some animal fodder, but these vegetables would not be appealing to most shoppers. The virus is particularly difficult to control because it is transmitted so rapidly to plants by the insect vectors"

Dr Walsh and his team identified the major gene involved in resistance to TuMV and discovered that the way in which it creates resistance is completely new. Using this knowledge, they found that it was possible to identify plants with an inherent resistance that could be used to speed up the breeding process and develop commercial varieties that are resistant to TuMV.

The team from University of Warwick are now working with industry partner Syngenta Seeds to breed resistance into Chinese cabbage. They hope in future to do the same with other crops such as broccoli, cabbage and kale.

Peter van der Toorn, R&D Lead Leafy Crops, Syngenta Seeds Vegetables said "Working in partnership with academic researchers is very important for us. Through such collaborations it's possible to take an idea from pre-commercial research and turn it into a new variety that can benefit the consumer and boost our contribution to the UK economy. We are very excited to be working together with academics at the University of Warwick to breed varieties with improved resistance to Turnip mosaic virus."

Professor Douglas Kell, BBSRC Chief Executive said "Bioscience research in all its forms has always given rise to developments that have impacts in society – whether predicted or serendipitous. Such developments need a structure through which to realise their potential and a partnership such as this one between the University of Warwick researchers and Syngenta will be important to ensure that resistance to diseases is incorporated into commercial crop varieties. These new resistant varieties would then be available to contribute towards future food security."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Organ procurement air transportation displays poor safety record

2010-11-19
The transplant community was largely unaware of sub-standard transportation practices for donor organs until a number of fatal air crashes took the lives of transplant personnel, calling attention to procurement aviation safety. A new report highlighting the need for improved safety measures in organ procurement travel appears in the December issue of Liver Transplantation, a peer-reviewed journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD). In the U.S., the Organ Procurement and Transplantation Network (OPTN) ...

Hormone therapy use may increase or decrease dementia risk depending upon timing

2010-11-19
OAKLAND, Calif. – Compared to women never on hormone therapy, those taking hormone therapy only at midlife had a 26 percent decreased risk of dementia; while women taking HT only in late life had a 48 percent increased risk of dementia, according to Kaiser Permanente researchers. Women taking HT at both midlife (mean age 48.7 years) and late life had a similar risk of dementia as women not on HT, according to the study which appears in the Annals of Neurology. The study was funded in part by the National Institutes of Health. Although previous research has shown that ...

Modulating a protein in the brain could help control Alzheimer's disease

2010-11-19
A protein known to exist in the brain for more than 30 years, called 5-lipoxygenase, has been found to play a regulatory role in the formation of the amyloid beta in the brain, the major component of plaques implicated in the development of Alzheimer's disease, according to researchers at Temple University's School of Medicine. The researchers also found that inhibitors of this protein currently used to control asthma could possibly be used to prevent or treat Alzheimer's disease. The researchers published their findings, "5-Lipoxygenase as Endogenous Modulator of Amyloid ...

Transcription factor scan identifies genetic cause for inherited blindness

2010-11-19
Retinitis pigmentosa is an inherited eye disorder characterized by progressive loss of vision that in many instances leads to legal blindness at the end stage. In a ChIP-Seq based approach, the researchers identified a key regulatory role of the transcription factor Crx (Cone-rod homeobox) in the expression of retina-specific genes and thus described an important genetic basis for visual perception. In-depth analysis of Crx mediated regulation in photoreceptors with latest technology provided by Genomatix lead then to the identification of nonsense mutations in the human ...

The enigma of the missing stars in space may be solved

2010-11-19
New stars are born in the Universe around the clock – on the Milky Way, currently about ten per year. From the birth rate in the past, we can generally calculate how populated space should actually be. But the problem is that the results of such calculations do not match our actual observations. "There should actually be a lot more stars that we can see," says Dr. Jan Pflamm-Altenburg, astrophysicist at the Argelander-Institut für Astronomie of the University of Bonn. So, where are those stars? For years, astronomers worldwide have been looking for a plausible explanation ...

Strike a pose: Research uncovers what's behind image in the modeling industry

2010-11-19
The casting sessions aren't just for movie stars, but what is involved in casting decisions that can launch fashion models to fame – or at the very least – to land a job? Stephanie Sadre-Orafai, a University of Cincinnati assistant professor and socio-cultural anthropologist, spent 11 months of fieldwork at a premiere casting agency in New York to uncover the decisions that happen behind the scenes of the glossy photos and slick commercials. Her research, "Polaroids and Go-Sees: Casting Encounters, Casting Epistemologies," was presented Nov. 17 at the 109th annual meeting ...

UTHealth discoveries shed more light on deadly thoracic aortic disease

2010-11-19
HOUSTON – (Nov. 18, 2010) – Discovery of a fifth gene defect and the identification of 47 DNA regions linked to thoracic aortic disease are the subject of studies released this month involving researchers at The University of Texas Health Science Center at Houston (UTHealth). In both studies, the investigators have identified alterations in the genetic material or DNA that affect the ability of smooth muscle cells, which line the aorta and other blood vessels, to contract. This can lead to a weakening of the wall of the aorta, the main blood vessel leading out of the ...

On the way to lead-free technology

On the way to lead-free technology
2010-11-19
Technical progress in the automobile industry is unbroken. But, the sector has still some hard nuts to crack: "Lead-free materials" is one of the challenges – hidden behind this challenge is a EU environmental directive which, based on a step-by-step plan, gradually bans all lead-containing materials and components from automotive vehicles – such as piezoelectric components. These elements are important for diesel engine injectors, for example, which control the supply of fuel to the combustion chamber. The problem: Up to now lead-zirconate-titanate (PZT) is the material ...

Conductor paths for marvelous light

Conductor paths for marvelous light
2010-11-19
A short push on the light switch – and the whole ceiling lights up in a uniform and pleasant color. This "illuminated sky" is not available as yet, but researchers from all over the world are working on it flat out. The technology behind this marvel is based on organic light-emitting diodes, or OLEDs for short. These diodes use special molecules to emit light as soon as current passes through them. Although the first OLEDs have only recently become available, they are small and expensive. A flat disk with a diameter of eight centimeters costs around Euro 250. Experts of ...

Compound that blocks sugar pathway slows cancer cell growth

2010-11-19
Scientists at Johns Hopkins have identified a compound that could be used to starve cancers of their sugar-based building blocks. The compound, called a glutaminase inhibitor, has been tested on laboratory-cultured, sugar-hungry brain cancer cells and, the scientists say, may have the potential to be used for many types of primary brain tumors. The Johns Hopkins scientists, are inventors on patent applications related to the discovery, caution that glutaminase inhibitors have not been tested in animals or humans, but their findings may spark new interest in the glutaminase ...

LAST 30 PRESS RELEASES:

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

[Press-News.org] New disease-resistant food crops in prospect